Delivery Order SPE2DB20D7059-SPE2DB24FQAH4
- Not listed
- Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania, has been awarded a firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 36,000 unit capsules of the pharmaceutical product CREON DR 100s. The potential value of this delivery order is $2,343.24, with a completion date of March 5, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 36,000 units of CREON DR 100s capsules. The $6,032.32 contract has a completion date of February 5, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, to deliver a...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the provision of 36,000 unit capsules of the pharmaceutical product CREON DR. The $2,458.62 contract has an ultimate completion date of April 9, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
- Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Cencora, Inc., was awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 24,000 units of CREON DR 100S capsules. The $1,357.76 contract has a completion date of February 1, 2024 and does not contain a set-aside designation. Amerisourcebergen Drug Corp is the prime contractor, providing pharmaceutical products and medical supplies to support military treatment programs and...
- Amerisourcebergen Drug Corp, a for-profit pharmaceutical distribution company, was awarded a delivery order contract worth $2,343.24 by the Defense Logistics Agency (DLA). The contract is for the supply of 36,000 units of the pharmaceutical product CREON DR 100S Capsules, with a completion date of February 28, 2024. This award is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, valued at up to $999,999,999.00, which serves as the primary vehicle...
- The U.S. Defense Logistics Agency (DLA) awarded a $98,647.61 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 24,000 units of the pharmaceutical product CREON DR 24,000 UNIT CAPSULE. The contract has an ultimate completion date of April 18, 2024. Amerisourcebergen Drug Corp's Corporate Office Division is the prime contractor for this award, which is not subject to any set-aside designation. Amerisourcebergen Drug...
- The U.S. Defense Logistics Agency (DLA) has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide 36,000 units of CREON DR 4563849287 capsules in 100-count packages. The potential value of this contract is $1,366.89 with a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor and no set-aside designation was used for this award. This delivery order is part of a larger indefinite...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division, a major pharmaceutical distributor. The $3,128.12 firm fixed price contract is for the supply of 36,000 unit capsules of the drug "CREON DR". The delivery order was issued under an Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing a...
- Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, was awarded a $2,404.44 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) to provide 36,000 units of the pharmaceutical product CREON DR 100s. The contract has a completion date of January 26, 2024 and does not have a set-aside designation. Amerisourcebergen Drug Corp holds an Indefinite Delivery Contract (IDC) with DLA with a potential value of $999,999,999.00 and a performance period...
- The U.S. Defense Logistics Agency (DLA) awarded a $1,282.77 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of 36,000 units of CREON DR 36,000 unit capsules. This delivery order was issued under an indefinite delivery contract (IDC) previously awarded to Amerisourcebergen Drug Corp with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary...
- SPE2DB20D7059Indefinite Delivery Contract
- SPE2DB20D7059-SPE2DB24FQAH4Delivery Order
Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, has been awarded a firm fixed price delivery order by the Defense Logistics Agency (DLA) to provide 24,000 units of the pharmaceutical product CREON DR 100S capsules. The $1,301.80 award has a completion date of March 5, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which serves as the primary contract vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. The IDC has a potential value of $999,999,999.00 and a performance period through December 31, 2025. No set-aside designation was used for this contract.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 3/4/24 |